Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids

Neuropharmacology

Volumn 44, Issue 6, 2003, Pages 749-755

  Alcalá, Maria Del Mar ^a   Vivas, Nuria María ^a   Hospital, Susana ^a   Camps, Pelayo ^a,b   Muñoz Torrero, Diego ^a,b   Badia, Albert ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

( ) Huprine Y; ( ) Huprine Z; AChE inhibitor; Alzheimer's disease; Huperzine A; Tacrine

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; HUPERZINE A; HUPRINE Y; HUPRINE Z; TACRINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0037401596     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00071-6     Document Type: Article

References (16)

1. Alvares A.P., Pratt W.B. Pathways of drug metabolism. Pratt W.B., Taylor P. Principles of Drug Action. The Basis of Pharmacology. 1990;365-422 Churchill Livingston, New York.
2. Bowen D.M., Benton J.S., Spillane J.A., Smith C.C., Allen S.J. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J. Neurol. Sci. 57:1982;191-202.
3. Camps P., El Achab R., Görbig D.M., Morral J., Muñoz-Torrero D., Badia A., Baños J.E., Vivas N.M., Barril X., Orozco M., Luque F.J. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. J. Med. Chem. 42:1999;3227-3242.
4. Camps P., Cusack B., Mallender W.D., El Achab R., Morral J., Muñoz-Torrero D., Rosenberry T.L. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for the treatment of Alzheimer's disease. Mol. Pharmacol. 57:2000;409-417.
5. Camps P., El Achab R., Morral J., Muñoz-Torrero D., Badia A., Baños J.E., Vivas N.M., Barril X., Orozco M., Luque F.J. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. J. Med. Chem. 43:2000;4657-4666.
6. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403.
7. Ellman G.L., Courtney K.D., Andres B., Featherstone R.M. Jr. New and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
8. Enz A., Amstutz R., Boddeke H., Gmelin G., Malanowski J. Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Prog. Brain Res. 98:1993;431-438.
9. Greig N.H., Utsuki T., Yu Q., Zhu X., Holloway H.W., Perry T., Lee B., Ingram D.K., Lahiri D.K. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase. Curr. Med. Res. Opin. 17:2001;159-165.
10. McKinney M., Miller J.H., Yamada F., Tuckmantel W., Kozikowski A.P. Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical AChE. Eur. J. Pharmacol. 203:1991;303-305.
11. Mesulam M., Guillozet A., Shaw P., Quinn B. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Neurobiol. Dis. 9:2002;88-93.
12. Perry E.K., Perry T.H., Blessed G., Tomlinson B.E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet. 1:1977;189.
13. Segel I.H. Enzyme Kinetics: Behaviour and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. 1975;John Wiley and Sons, New York. (pp. 107-111, 132-134).
14. Snape M.F., Misra A., Murray T.K., De Souza R.J., Williams J.L., Cross A.J., Green A.R. A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology. 38:1999;181-193.
15. Sugimoto H., Iimura Y., Yamanishi Y., Yamatsu K. Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds. J. Med. Chem. 38:1995;4821-4829.
16. Tang X.C., Han Y.F. Pharmacological profile of huperzine A, a novel acetylcholinesterase inhibitor from Chinese herb. C.N.S. Drug Rev. 5:1999;281-300.